Anthem Biosciences Limited IPO GMP

Anthem Biosciences is an innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization (“CRDMO”) with fully integrated operations spanning across drug discovery, development and manufacturing. They are one of the few companies in India with integrated New Chemical Entity (“NCE”) and New Biological Entity (“NBE”) capabilities across drug discovery, development, and commercial manufacturing.

Anthem Biosciences, an Book Built Issue, amounting to ₹ 3,395.00 Crores, consisting entirely an Offer for Sale of 595.61 Lakhs Shares. The subscription period for the Anthem Biosciences IPO opens on July 14, 2025, and closes on July 16, 2025. The allotment is expected to be finalized on or about Thursday, July 17, 2025, and the shares will be listed on the BSE & NSE with a tentative listing date set on or about Monday, July 21, 2025.

The Share Price Band of Anthem Biosciences IPO is set at ₹ 540 to ₹ 570 per equity share. The Market Capitalisation of the Anthem Biosciences at IPO price of ₹ 570 per equity share will be ₹ 32,011.77 Crores. The lot size of the IPO is 26 shares. Retail investors are required to invest a minimum of ₹ 14,820 (26 shares), while the minimum investment for High-Net-Worth Individuals (HNIs) is 14 lots (364 shares), amounting to ₹ 2,07,480.

JM Financial Limited, Citigroup Global Markets India Private Limited, J.P. Morgan India Private Limited and Nomura Financial Advisory and Securities (India) Private Limited are the book running lead manager of the Anthem Biosciences, while KFin Technologies Limited is the registrar for the issue. 

Anthem Biosciences Limited IPO GMP Today
The Grey Market Premium of Anthem Biosciences IPO is expected to be ₹ 70 based on the financial performance of the company. No real trading is done on the basis of Grey Market Premium that's why no real discovery of price can be done before the listing of shares on the stock exchange. The Grey Market Premium totally depends upon the Demand and Supply of the shares of the company in unorganized manner which is not recommended. The Grey Market Premium is mentioned for educational and informational purposes only.

Anthem Biosciences Limited IPO Live Subscription Status Today: Real-Time Update
As of 07:00 PM on 16 July, 2025, the Anthem Biosciences Limited IPO live subscription status shows that the IPO subscribed 63.86 times on its Final Day of subscription period. Check the Anthem Biosciences IPO Live Subscription Status Today at BSE.

Anthem Biosciences IPO Anchor Investors Report
Anthem Biosciences has raised ₹ 1,016.02 Crores from Anchor Investors at a price of ₹ 570 per shares in consultation of the Book Running Lead Managers. The company allocated 1,78,24,999 equity shares to the Anchor Investors. Check Full List of Anthem Biosciences Anchor Investor List.

Note:- Equity Shares allotted to Anchor Investors (if any) are allotted from Qualified Institutional Buyers (QIBs) reservation portion.
Note:- The Number of shares offered shown IPO subscription section table is calculated at the lower end of the price band and Number of shares calculated in IPO details table section is calculated at upper end of the price band in case of Book Building Issue, so there can be difference. This is because we assume shares will be issued by the company at upper band as Anchor Investors also subscribe at upper band and shares will be issued at lower band only if in case of undersubscription of IPO.
Note:- Market Maker portion (if any) are not shown separately in subscription table and included in NIIs reservation portion.

Anthem Biosciences Limited Day Wise IPO GMP Trend

Anthem Biosciences Limited IPO Allotment Date - Step by Step Guide to Check Allotment Status Online
Anthem Biosciences IPO allotment date is 17 July, 2025, Thursday. Anthem Biosciences IPO Allotment will be out on 17th July, 2025 and will be live on Registrar Website from the allotment date. Check Anthem Biosciences IPO Allotment Status here. Here's how you can check the allotment status:
- Navigate to the IPO allotment status page.
- Select Anthem Biosciences Limited IPO from the dropdown list of IPOs
- Enter your application number, PAN, or DP Client ID
- Submit the details to check your allotment status.
By following either of these methods, investors can quickly determine their allotment status and proceed accordingly with their investments.

Objectives of Anthem Biosciences Limited IPO
Anthem Biosciences will not receive any proceeds from the Offer (the “Offer Proceeds”) and all the Offer Proceeds will be received by the Selling Shareholders after deduction of Offer related expenses and relevant taxes thereon, to be borne by the respective Selling Shareholders.

Refer to Anthem Biosciences Limited RHP for more details about the Company.